Form 4 Tracker
Eric A Hughes

Director; See "Remarks" · 6 filings · Latest: Aug 3, 2026

Monte Rosa Therapeutics, Inc.
TEVA PHARMACEUTICAL INDUSTRIES LTD
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TEVA
Eric A HughesSee "Remarks"Aug 3, 2026
Sale
$34.8825,578$892.1K134,877
TEVA
Eric A HughesSee "Remarks"Aug 3, 2026
Option Exercise
—52,744—160,455
TEVA
Hughes Eric A—Aug 3, 2026
Proposed Sale
$34.8825,578$892.1K—
TEVA
Eric A HughesSee "Remarks"Mar 5, 2026
Sale
$31.679,533$301.9K107,711
TEVA
Eric A HughesSee "Remarks"Mar 5, 2026
Option Exercise
—19,654—117,244
TEVA
Eric A HughesSee "Remarks"Mar 4, 2026
Sale
$32.4611,277$366.1K97,590
TEVA
Eric A HughesSee "Remarks"Mar 4, 2026
Option Exercise
—23,251—108,867
TEVA
Hughes Eric A—Mar 5, 2026
Proposed Sale
$31.679,533$301.9K—
TEVA
Eric A HughesSee "Remarks"Mar 3, 2026
Sale
$32.3680,762$2.6M85,616
TEVA
Eric A HughesSee "Remarks"Mar 3, 2026
Option Exercise
—166,378—154,301
TEVA
Hughes Eric A—Mar 4, 2026
Proposed Sale
$32.4611,277$366.1K—
TEVA
Hughes Eric A—Mar 3, 2026
Proposed Sale
$32.3680,762$2.6M—
TEVA
Hughes Eric A—Aug 1, 2025
Proposed Sale
$15.1652,742$799.4K—
TEVA
Hughes Eric A—Mar 4, 2025
Proposed Sale
$16.0023,251$372.0K—
TEVA
Hughes Eric A—Mar 3, 2025
Proposed Sale
$16.4624,900$409.9K—